Companies Cryptocurrencies
Alector Inc
Alector Inc
Exchange: NasdaqGS
IPO Date: 07/02/2019
CEO: DR. Arnon Rosenthal
Biotechnology Healthcare 🔗
  • ALEC
  • 22.52
  • 1821314048
    market cap
  • -0.289999
If you bought

shares of Alector Inc (ALEC) on
You would have made
Old Price $12 Current Price $12

Alector, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in South San Francisco, California and currently employs 109 full-time employees. Immuno-neurology targets immune dysfunction as a cause of multiple pathologies that are drivers of degenerative brain disorders. The firm is developing therapies designed to simultaneously counteract these pathologies by restoring healthy immune function to the brain. The firm’s platform leverages large scale human genetic datasets, advanced tools in bioinformatics and imaging, and insights into neurodegeneration and immunology to identify immune system. Its platform focuses on target selection, biomarker selection and patient selection. Its product portfolio includes AL001, AL101, Al002 and AL003. Its AL001 targets frontotemporal dementia carrying a progranulin (FTD-GRN).

Address: 151 Oyster Point Blvd Ste 300 South San Francisco CALIFORNIA 94080

Stay updated.